ALEXANDRIA REAL ESTATE EQ IN shareholders Q2 2022

ALEXANDRIA REAL ESTATE EQ IN's ticker is ARE and the CUSIP is 015271109. A total of 606 filers reported holding ALEXANDRIA REAL ESTATE EQ IN in Q2 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

ALEXANDRIA REAL ESTATE EQ IN shareholders Q2 2022
NameSharesValueWeighting ↓
APG Asset Management US Inc. 6,852,982$1,015,132,0006.94%
Ranger Global Real Estate Advisors, LLC 1,004,459$73,938,0005.95%
Waterfront Capital Partners, LLC 594,971$86,289,0005.82%
Vision Capital Corp 156,832$22,745,0005.31%
B&I Capital AG 104,247$15,119,0004.89%
Hazelview Securities Inc. 229,749$34,306,0004.60%
Masterton Capital Management, LP 26,256$3,808,0004.57%
Vert Asset Management LLC 29,703$4,308,0003.99%
Land & Buildings Investment Management 112,498$16,316,0003.73%
Adelante Capital Management LLC 399,670$57,964,0003.49%
Socorro Asset Management LP 63,652$9,231,0003.28%
GARLAND CAPITAL MANAGEMENT INC 29,840$4,328,0003.23%
AEW CAPITAL MANAGEMENT L P 557,573$80,865,0003.04%
Presima Securities ULC 84,600$12,270,0003.01%
HAHN CAPITAL MANAGEMENT LLC 72,623$10,532,514,0002.78%
American Assets Capital Advisers, LLC 124,870$18,110,0002.73%
GSI Capital Advisors LLC 42,210$6,122,0002.69%
CBRE INVESTMENT MANAGEMENT LISTED REAL ASSETS LLC 935,127$135,621,0002.13%
Uniplan Investment Counsel, Inc. 203,888$29,569,0002.06%
NFJ INVESTMENT GROUP, LLC 561,978$81,504,0001.95%
About ALEXANDRIA REAL ESTATE EQ IN

Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) that specializes in the ownership, operation, and development of life science and technology properties. The company is headquartered in Pasadena, California, and has a portfolio of over 33 million square feet of rentable space across key innovation clusters in the United States, Canada, and the United Kingdom.

ARE's focus on life science and technology properties has proven to be a wise investment strategy, as the demand for these types of properties has increased in recent years. The company's properties are home to some of the world's leading pharmaceutical, biotechnology, and technology companies, making it a key player in the industry.

In addition to its impressive portfolio, ARE has a strong financial position, with a market capitalization of over $30 billion and a debt-to-equity ratio of just 0.67. The company has also consistently delivered strong financial results, with a 5-year average revenue growth rate of 16.5% and a 5-year average return on equity of 6.9%.

ARE's leadership team is also impressive, with Joel Marcus serving as the company's Executive Chairman and Peter Moglia as its Chief Financial Officer. Both Marcus and Moglia have extensive experience in the real estate industry and have been instrumental in the company's success.

Overall, Alexandria Real Estate Equities, Inc. is a strong player in the life science and technology real estate market, with a solid portfolio, strong financials, and experienced leadership team. Investors looking for exposure to this growing industry may want to consider adding ARE to their portfolios.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists ALEXANDRIA REAL ESTATE EQ IN's shareholders in Q2 2022. To view ALEXANDRIA REAL ESTATE EQ IN's shareholder history, click here.